|
Volumn 26, Issue 3, 2005, Pages 497-499
|
Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CIPROFLOXACIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLIMEPIRIDE;
INSULIN;
ISOPHANE INSULIN;
METFORMIN;
METHYLDOPA;
RAMIPRIL;
SIMVASTATIN;
TETRAHYDROLIPSTATIN;
THIOCOLCHICOSIDE;
ADULT;
APGAR SCORE;
ARTICLE;
BODY MASS;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
INFANT;
METABOLIC SYNDROME X;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PRESCRIPTION;
SECOND TRIMESTER PREGNANCY;
TERATOGENICITY;
THIRD TRIMESTER PREGNANCY;
URINARY TRACT INFECTION;
VAGINAL DELIVERY;
ADULT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTI-OBESITY AGENTS;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
LACTONES;
METABOLIC SYNDROME X;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PREGNANCY OUTCOME;
RAMIPRIL;
SULFONYLUREA COMPOUNDS;
|
EID: 17844387339
PISSN: 03795284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (5)
|